Gene: TEX41

401014
DKFZp686O1327|LINC00953
testis expressed 41
ncRNA
2q22.3
Ensembl:ENSG00000226674
NC_000002.12
SNP Mapped
7   ANCO-SNPs
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.671e-1 (AD)  1.551e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs10496968chr2:144766679 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs11883829chr2:144762056 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs1351734chr2:144729026 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs4471836chr2:144717578 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs10496966chr2:144701195 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs2195115chr2:144688638 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs980772chr2:144684623 (GRCh38.p7)G>A / G>Talcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
BMP50.779
FOXD20.753
BMX0.745
SLC17A30.735
MYOCD0.726
GADL10.715
SCARA50.695
PTGDR0.693
IRF60.692
TRABD2B0.686

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SORCS2-0.344
CADM1-0.313
CDH20-0.312
SLC6A11-0.311
LRP4-0.307
NTSR2-0.305
CNTFR-0.303
IGSF11-0.301
GABRG1-0.301
CABLES1-0.297

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX41 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX41 mRNA"27188386
D002392Catechin[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TEX41 mRNA24763279
C511402Grape Seed Proanthocyanidins[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TEX41 mRNA24763279
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of TEX41 mRNA28065790
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX41 mRNA"27188386

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

There is no Interaction data for this gene.

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal